These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9455706)

  • 1. Specific monoclonal antibody raised against the p33ING1 tumor suppressor.
    Garkavtsev I; Boland D; Mai J; Wilson H; Veillette C; Riabowol K
    Hybridoma; 1997 Dec; 16(6):537-40. PubMed ID: 9455706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of CAb antibodies recognize endogenous and ectopically expressed ING1 protein.
    Boland D; Olineck V; Bonnefin P; Vieyra D; Parr E; Riabowol K
    Hybridoma; 2000 Apr; 19(2):161-5. PubMed ID: 10868796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumour suppressor p33ING1 does not regulate migration and angiogenesis in melanoma cells.
    Cheung KJ; Li G
    Int J Oncol; 2002 Dec; 21(6):1361-5. PubMed ID: 12429989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of calcyclin binding protein (CacyBP) monoclonal antibody.
    Zhai H; Shi Y; Yu J; Hong L; Tang H; Wang J; Hu S; Bai F; Fan D
    Hybridoma (Larchmt); 2006 Apr; 25(2):91-4. PubMed ID: 16704310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear exclusion of p33ING1b tumor suppressor protein: explored in HCC cells using a new highly specific antibody.
    Sayan B; Emre NC; Irmak MB; Ozturk M; Cetin-Atalay R
    Hybridoma (Larchmt); 2009 Feb; 28(1):1-6. PubMed ID: 19132896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.
    Garkavtsev I; Grigorian IA; Ossovskaya VS; Chernov MV; Chumakov PM; Gudkov AV
    Nature; 1998 Jan; 391(6664):295-8. PubMed ID: 9440695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple method of monoclonal antibody production against mammalian cellular prion protein.
    Liu YS; Ding YZ; Zhang J; Chen HT; Zhu XL; Cai XP; Liu XT; Xie QG
    Hybridoma (Larchmt); 2010 Feb; 29(1):37-43. PubMed ID: 20199150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumour suppressor p33ING1 does not enhance camptothecin-induced cell death in melanoma cells.
    Cheung KJ; Li G
    Int J Oncol; 2002 Jun; 20(6):1319-22. PubMed ID: 12012016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of a monoclonal anti CK-2 alpha subunit antibody of the IgG1 subclass.
    Schmidt-Spaniol I; Boldyreff B; Issinger OG
    Hybridoma; 1992 Feb; 11(1):53-9. PubMed ID: 1737640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The production and characterization of murine monoclonal antibodies to human Gadd45 raised against a recombinant protein.
    Kilpatrick KE; Carrier F; Smith ML; Chen CY; Lee AJ; Rusnak DW; Kastan MB; Fornace AJ; Champion BR; Gilmer TM
    Hybridoma; 1995 Aug; 14(4):355-9. PubMed ID: 8522347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of monoclonal antibodies against tuberous sclerosis complex 2.
    Malanchuk O; Palchevskyy S; Ovcharenko G; Gwalter J; Pozur V; Gout I; Filonenko V
    Hybridoma (Larchmt); 2007 Aug; 26(4):259-66. PubMed ID: 17725389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of rat monoclonal antibodies against RNA-binding protein Hzf.
    Nakamura H; Asai A; Maruyama M; Sugimoto M
    Hybridoma (Larchmt); 2010 Feb; 29(1):7-11. PubMed ID: 20199145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor suppressors p33ING1 and p33ING2 interact with alien in vivo and enhance alien-mediated gene silencing.
    Fegers I; Kob R; Eckey M; Schmidt O; Goeman F; Papaioannou M; Escher N; von Eggeling F; Melle C; Baniahmad A
    J Proteome Res; 2007 Nov; 6(11):4182-8. PubMed ID: 17929852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1).
    Garkavtsev I; Demetrick D; Riabowol K
    Cytogenet Cell Genet; 1997; 76(3-4):176-8. PubMed ID: 9186514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies generated against recombinant ATM support kinase activity.
    Alligood KJ; Milla M; Rhodes N; Ellis B; Kilpatrick KE; Lee A; Gilmer TM; Lansing TJ
    Hybridoma; 2000 Aug; 19(4):317-21. PubMed ID: 11001404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of murine monoclonal antibody against synthetic peptide of CD34.
    Maleki LA; Majidi J; Baradaran B; Abdolalizadeh J; Akbari AM
    Hum Antibodies; 2013; 22(1-2):1-8. PubMed ID: 24284303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of a novel monoclonal antibody specific to peptide VEHVVADAGAFLRH.
    Cao J
    Hybridoma (Larchmt); 2009 Feb; 28(1):59-62. PubMed ID: 19207013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of a specific monoclonal antibody against CIAPIN1.
    Hao Z; Qiao T; Jin X; Li X; Gao J; Fan D
    Hybridoma (Larchmt); 2005 Jun; 24(3):141-5. PubMed ID: 15943561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of isoform-specific monoclonal antibodies against human IL-18 binding protein.
    Lee S; Kim S; Bae S; Choi J; Hong J; Ryoo S; Jhun H; Hong K; Kim E; Jo S; Her E; Kim S
    Hybridoma (Larchmt); 2010 Dec; 29(6):517-24. PubMed ID: 21087098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele-specific monoclonal antibodies against glutathione S-transferase Mu1-1.
    Juronen E; Tasa G; Uusküla M; Parik J; Mikelsaar AV
    Hybridoma; 1994 Dec; 13(6):477-84. PubMed ID: 7537719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.